Goldsmith Mark Ainsider trades
In SEC Form 4 filings, Goldsmith Mark A is listed as See Remarks of Revolution Medicines, Inc. (RVMD). In the last 90 days, Goldsmith Mark A sold $20.78M of Revolution Medicines, Inc. (RVMD) on the open market and bought none. All 20 sales were reported under a 10b5-1 trading plan.
Companies and roles
| Company | Role | Transactions | Last filed |
|---|---|---|---|
| RVMDRevolution Medicines, Inc. | See Remarks | 22 | Sep 18 |
Cluster buys
No cluster buy in the last 90 days included a purchase by this insider (two or more insiders buying within 14 days).
Form 4 historysince 2026-08-25
| Company | Traded | Filed | Type | Shares | Price | Value | Owned after | 10b5-1 plan | Filing |
|---|---|---|---|---|---|---|---|---|---|
| RVMDRevolution Medicines, Inc. | Sep 16 | Sep 18 | S | 213 | $195.01 | Sale −$41,537 | 267,117 | Yes | Form 4 |
| RVMDRevolution Medicines, Inc. | Sep 16 | Sep 18 | S | 13,775 | $199.30 | Sale −$2,745,402 | 253,342 | Yes | Form 4 |
| RVMDRevolution Medicines, Inc. | Aug 21 | Aug 25 | M | 80,000 | $4.73 | $378,400 | 347,330 | Yes | Form 4 |
| RVMDRevolution Medicines, Inc. | Aug 21 | Aug 25 | S | 5,128 | $207.23 | Sale −$1,062,691 | 342,202 | Yes | Form 4 |
| RVMDRevolution Medicines, Inc. | Aug 21 | Aug 25 | S | 24,917 | $208.37 | Sale −$5,191,948 | 317,285 | Yes | Form 4 |
| RVMDRevolution Medicines, Inc. | Aug 21 | Aug 25 | S | 35,938 | $209.26 | Sale −$7,520,440 | 281,347 | Yes | Form 4 |
| RVMDRevolution Medicines, Inc. | Aug 21 | Aug 25 | S | 3,813 | $210.25 | Sale −$801,670 | 277,534 | Yes | Form 4 |
| RVMDRevolution Medicines, Inc. | Aug 21 | Aug 25 | S | 6,583 | $211.33 | Sale −$1,391,206 | 270,951 | Yes | Form 4 |
| RVMDRevolution Medicines, Inc. | Aug 21 | Aug 25 | S | 3,621 | $212.08 | Sale −$767,933 | 267,330 | Yes | Form 4 |
| RVMDRevolution Medicines, Inc. | Aug 21 | Aug 25 | S | 190 | $207.25 | Sale −$39,377 | 64,234 | Yes | Form 4 |
| RVMDRevolution Medicines, Inc. | Aug 21 | Aug 25 | S | 951 | $208.36 | Sale −$198,155 | 63,283 | Yes | Form 4 |
| RVMDRevolution Medicines, Inc. | Aug 21 | Aug 25 | S | 1,351 | $209.28 | Sale −$282,739 | 61,932 | Yes | Form 4 |
| RVMDRevolution Medicines, Inc. | Aug 21 | Aug 25 | S | 136 | $210.40 | Sale −$28,615 | 61,796 | Yes | Form 4 |
| RVMDRevolution Medicines, Inc. | Aug 21 | Aug 25 | S | 245 | $211.47 | Sale −$51,809 | 61,551 | Yes | Form 4 |
| RVMDRevolution Medicines, Inc. | Aug 21 | Aug 25 | S | 127 | $212.06 | Sale −$26,932 | 61,424 | Yes | Form 4 |
| RVMDRevolution Medicines, Inc. | Aug 21 | Aug 25 | S | 177 | $207.25 | Sale −$36,684 | 64,247 | Yes | Form 4 |
| RVMDRevolution Medicines, Inc. | Aug 21 | Aug 25 | S | 937 | $208.36 | Sale −$195,234 | 63,310 | Yes | Form 4 |
| RVMDRevolution Medicines, Inc. | Aug 21 | Aug 25 | S | 1,405 | $209.27 | Sale −$294,019 | 61,905 | Yes | Form 4 |
| RVMDRevolution Medicines, Inc. | Aug 21 | Aug 25 | S | 126 | $210.40 | Sale −$26,511 | 61,779 | Yes | Form 4 |
| RVMDRevolution Medicines, Inc. | Aug 21 | Aug 25 | S | 229 | $211.46 | Sale −$48,425 | 61,550 | Yes | Form 4 |
| RVMDRevolution Medicines, Inc. | Aug 21 | Aug 25 | S | 126 | $212.06 | Sale −$26,720 | 61,424 | Yes | Form 4 |
| RVMDRevolution Medicines, Inc. | Aug 21 | Aug 25 | M · derivative | 80,000 | $4.73 | $378,400 | 344,085 | Yes | Form 4 |
Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.